Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Cost of Revenue

$576.50M

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Cost of Revenue

Latest reported$576.50Mperiod endingJun 30, 2026

Latest reported$576.50Mperiod endingJun 30, 2026

REGN Quarterly Cost of Revenue ($0.00 → $576.50M)

Quarterly cost of revenue

High-resolution chart · PNG

REGN cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	1,885,000
Mar 31, 2001	2,188,000
Dec 31, 2000	8,738,000
Sep 30, 2000	2,512,000
Jun 30, 2000	1,265,000
Mar 31, 2000	3,051,000
Dec 31, 1999	100,000
Sep 30, 1999	1,000,000
Jun 30, 1999	1,200,000
Mar 31, 1999	1,300,000
Dec 31, 1998	1,600,000
Sep 30, 1998	1,300,000
Jun 30, 1998	1,200,000
Mar 31, 1998	900,000
Dec 31, 1997	900,000
Sep 30, 1997	800,000
Jun 30, 1997	500,000
Mar 31, 1997	500,000
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	10,600,000
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	5,000,000
Sep 30, 1991	2,400,000
Jun 30, 1991	2,900,000
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.